Categories: HealthcareNews

InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

TEL AVIV, Israel and MIAMI, April 03, 2024 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that Marvin Slosman, Chief Executive Officer, will deliver a company update presentation at the 23rd Annual Needham Virtual Healthcare Conference, which is being held April 8-11, 2024.

Presentation details:

Date: Wednesday, April 10th
   
Time: 8:00-8:40 AM ET
   
Webcast: https://wsw.com/webcast/needham138/nspr/2290730, or on the Events section of the company’s Investor Relations website at https://www.inspiremd.com/en/events/.
   

About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on the Nasdaq under the ticker symbol NSPR.

We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.

Investor Contacts:

Craig Shore
Chief Financial Officer
InspireMD, Inc.
888-776-6804
craigs@inspiremd.com

Chuck Padala, Managing Director
LifeSci Advisors
646-627-8390
chuck@lifesciadvisors.com
investor-relations@inspiremd.com

Staff

Recent Posts

AnswersNow Named Best Telehealth Platform in 2025 MedTech Breakthrough Awards

Transformational virtual provider of autism therapy provides fast, convenient access to quality care for families…

18 minutes ago

Alpha Pro Tech, Ltd. Announces First Quarter 2025 Financial Results

Total Sales Increased by 2.5% to $13.8 Million, Compared to the Prior Year PeriodNet sales…

18 minutes ago

HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 – Featuring CEO Andrew Simpson

Southlake, TX, May 08, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq:HSCS) ("HeartSciences" or the "Company"),…

19 minutes ago

Wellgistics Health Secures $50M ELOC facility for XRP Treasury Reserve & Real-Time Payments Infrastructure and other general ops

Tampa, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ: WGRX), a technology-first…

19 minutes ago

LiveWorld Reports First Quarter 2025 Financial Results

LiveWorld looks to increase its AI investmentCAMPBELL, Calif. and NEW YORK , May 08, 2025…

19 minutes ago

Dogwood Therapeutics Announces First Quarter 2025 Financial Results

- Dogwood Therapeutics, Inc. commenced dosing of patients in the Halneuron® Chemotherapy Induced Neuropathic Pain…

19 minutes ago